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Children with cerebral palsy have an increased risk of fracture and low bone mass. A systematic review
was carried out to identify the associated or risk factors. The role of bone mineral density measurement
(particularly whole-body or distal femur) by dual-energy X-ray absorptiometry and quantitative
computed tomography is examined. Current strategies to prevent or treat the bone fragility in children
with cerebral palsy are summarised.
中 文 摘 要
腦癱兒童有較高骨折和低骨質量的風險，現就其相關或風險因素，進行了系統性探討， 檢測雙能X光骨密度
儀及量化電腦掃描應用於量度骨質密度（全身或股骨下端）的角色，並總結了防治腦癱兒童的骨質脆弱性的
現行策略。Introduction
Cerebral palsy (CP) describes a group of permanent disorders of
the development of movement and posture, causing activity limi-
tation, that are attributed to non-progressive disturbances occur-
ring in the developing fetal or infant brain. Its population-based
prevalence has been reported as 1.2e3.6 per 1000 live births.1
Among the physiological subtypes, spasticity is the most common
(77e93%), followed by dyskinesias (2e15%) and ataxia (2e8%),
isolated hypotonia (0.7e2.6%) being the least common physiolog-
ical subtype.1 Regarding the body part affected, total-body/
quadriplegic-type CP and diplegic-type CP are more common
than hemiplegic-type.
Cerebral palsy is one of the most common physical disabilities of
childhood. The motor disorders of CP are often accompanied by
disturbances of sensation, perception, cognition and communica-
tion, and by behaviour problems. In population-based surveys, the
frequency of impairments is substantial, 70% of individuals
showing mental retardation (IQ < 70) and 31e40% having ongoing
epilepsy, 21e63% visual impairment and 11e13% hearing impair-
ment.1 Musculoskeletal problems include spasticity or other
movement disorders, muscle and joint contractures, joint defor-
mities, hip instability, scoliosis, gait disturbance and fractures.ngOrthopaedicAssociationandHongKoFractures in children with cerebral palsy
Fractures are not uncommon in children with CP. In one series,
39% of childrenwith quadriplegic CP gave a history of fracture.2 The
prevalence rate was 6% in 1637 patients with CP,3 and 12% in
another 763 children with CP.4 A higher prevalence rate of 23% was
reported in 88 children with quadriplegic CP.5 The fracture inci-
dence was estimated to be 4.8 per 100 personeyears among one
study of 261 children with moderate-to-severe CP.6 Thus, the
fracture incidence in children with CP is much higher than that in
the general paediatric population.
The causes of fracture were not identiﬁed for 55% of individuals
in one series.3 These fractures occur with minimal trauma or are
‘spontaneous’ with no apparent history of injury. The diagnosis is
thus delayed or even missed in those patients who cannot
communicate. Even when there is clinical suspicion of a fracture,
some low-energy metaphyseal fractures do not show up on plain
radiography and can only be diagnosed with whole-body bone
scanning.7 Thus, bone fragility seems to be an underlying problem
related to these ‘spontaneous’ fractures.
One retrospective review identiﬁed 35 non-ambulatory children
with quadriplegic spastic CP, all of Gross Motor Functional Classi-
ﬁcation System (GMFCS) level V, who had 57 ‘spontaneous frac-
tures’ during the period 1993e2005 in an institution providing
inpatient services to 200e250 severely mental handicappedngCollegeofOrthopaedic Surgeons. PublishedbyElsevier (Singapore) Pte Ltd.All rights reserved.
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excluded. As in most series, the most common site of fractures was
the lower limb, almost 80% of fractures occurring around the knee
and being metaphyseal fractures of the lower limb. One-third of
children had recurrent fractures, and 17% of fractures occurred
within 1 year after lower limb surgery.
Fractures in children with CP are associated with a higher
complication rate than fractures in healthy children. In a study of
156 children with CP who sustained fractures,3 there were 7 repeat
fractures, 5 malunions, 4 cases of delayed consolidation or non-
union, 4 with infection and 3 cases of pneumonia. The frequency
of complications was 17% of all patients and 10.5% of all those with
fractures.
Risk factors associated with fractures in children with
cerebral palsy
The severity of neurological involvement is an important factor.
Children with CP who are non-ambulatory4 and classiﬁed as GMFC
level V9 have the highest risk. Contractures and stiffness of the
major joints create long lever arms also predisposed to fracture.
Previous fracture is associated with increased fracture risk,6 the
fracture rate increasing more than threefold after a previous
fracture.10
Fractures after lower limb surgery, particularly after hip
osteotomy and surgery related to a hip spica cast, were observed in
several studies. In a retrospective review of fractures in severely
handicapped institutionalized children and young adults, 6 of 21
(29%) non-ambulatory patients had a femur fracture within 3
months of removal of a hip spica cast and operation for subluxed or
dislocated hip, compared with 4 of 37 (11%) non-ambulatory
patients who did not have hip surgery.11
In another retrospective review of 79 children with CP who
underwent osteotomy for subluxation of the hip, 16 (20%) children
sustained fractures, all of which were managed with cast or splint
immobilization.12 Indeed, the calculated fracture rate was 4.5 times
higher after a hip spica cast than in those who not have a spica
cast.10
Postoperative bone loss is found to be enormous even in normal
children who are subject to a brief period of immobilization. In
a study of preoperative and postoperative dual-energy X-ray
absorptiometry (DXA) for 15 healthy children undergoing lower
extremity surgery with a minimum of 4 weeks of either non-
weight-bearing or cast immobilization, the average loss of BMD
was 16.5% in cancellous regions, 11.5% in transitional bone and 4.8%
in the cortical bone of the operated leg within 6 weeks, and the
z-score fell by 1.0 for cancellous bone, 0.75 for transitional bone and
0.45 for cortical bone.13 Thus, prolonged immobilization with or
without surgery can predispose to fracture in children with CP.
Oro-motor difﬁculty is a common co-morbidity in CP. Poor lip
closure, inadequate jaw control and a delay in swallowing and
sucking are common oro-motor difﬁculties. Ryles tube feeding or
gastrostomy is commonly used as the last resort in providing
enteral feeding when faced with severe feeding difﬁculty. Indeed,
Ryles tube feeding4 and gastrostomy use6 are associated with an
increased fracture risk. However, even mild feeding difﬁculty can
result in malnutrition. In a survey of 235 children with moderate-
to-severe CP, 47% had a body weight below the ﬁfth percentile,
and one-third had an upper arm fat and muscle area below the 10th
percentile.14 Weight-for-age z-score was one of the important
independent predictors of fracture risk in a multivariate analysis of
children with CP.15
Low vitamin D status is common in childrenwith CP. Using a 25-
hydroxy vitamin D level of less than 20 ng/mL as a biochemical
indicator of low vitamin D status, it has been found that theprevalence of low vitamin D status was 19% among childrenwith CP
living in a community, compared with less than 2% in the healthy
paediatric population.10 The prevalence is expected to be much
higher in childrenwith moderate or severe CP living in institutions.
In one study, all 20 children and young adults with CP and patho-
logical long bone fractures showed radiological and biochemical
evidence of rickets or osteomalacia.5
Besides feeding difﬁculties and inadequate exposure to sunlight,
the use of antiepileptic drugs (AED) also contributes to low vitamin
D status. Local studies in children with CP showed that 30% of
children living in a community had epilepsy16 and 63% of children
living in institutions were taking AEDs.15 In severely mentally
retarded children who had been receiving AEDs for more than 10
years, up to 75% had osteomalacia.17 Furthermore, a signiﬁcant
relationship between the number of pathological long bone frac-
tures and the use of AEDs was demonstrated in institutionalized
residents with CP.5
In summary, severe neurological impairment (non-ambulatory
status, GMFCS level V), severe joint contracture, a history of frac-
ture, prolonged immobilization (particularly the use of a hip spica),
malnutrition (Ryles tube feeding or gastrostomy, low body weight
z-score) and use of AEDs are known to be associated with an
increased fracture risk in children with CP.Bone mineral density in children with cerebral palsy
As children have not yet reached peak bone mass, it is not
appropriate to use the t-score. Instead, the z-score adjusted for age
and sex should be used. When the z-score is less than or equal
to 2.0, there is ‘low bone mass for chronological age’. The diag-
nosis of osteoporosis in children, as deﬁned by the International
Society for Clinical Densitometry, includes a bone mineral density
(BMD) z-score of less than 2.0 adjusted for age, gender and body
size, plus a clinically signiﬁcant fracture history: either (1) two
upper extremity fractures, or (2) a vertebral compression fracture,
or (3) a single lower limb fracture.18 Indeed, CP is the most preva-
lent childhood condition associated with osteoporosis.
In children with CP, the rate of bone mineral acquisition is
diminished relative to normal; thus, the BMD and bone mineral
content (BMC) are lower than age-matched normal values. With
growth, BMD falls further below normal with increasing age.10 In
spite of an average of 2e5% per year increase in BMD in the distal
femur, the BMD z-score decreases further with increasing age.19 In
a heterogeneous group of 139 childrenwith spastic CP, BMDwas on
average nearly 1 standard deviation below the age-matched
normal means for both the hip and the lumbar spine.20 In
another study of children with quadriplegic CP of heterogeneous
GMFC level, 58% of children had a z-score of less than 2.0.2
Poor mobility status predicts a low BMD in children with CP:
97% of non-ambulatory children older than 9 years with moderate-
to-severe CP had a distal femur z-score of less than 2.0.10 Signif-
icantly lower z-scores on lumbar spine BMDwere found in patients
with a history of fracture.2
Nearly all AEDs have an adverse effect on bonemass and BMD in
children. The most well known are phenytoin and phenobarbital,
which are inducers of cytochrome P450 enzymes leading to the
catabolism of vitamins. Treatment with phenytoin and phenobar-
bital can be associated with rickets. More recently established AEDs
such as valproic acid, carbamazepine and oxacarbazepine have
been shown to be associated with decreased BMD.21
Using stepwise regression analysis, severity of neurological
impairment, increased feeding difﬁculty, use of AEDs and lower
triceps skinfold measurement were identiﬁed as risk factors (in
decreasing order of importance) for low BMD in the distal femur of
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z-score was the best predictor of BMD z-score.22
In summary, children with CP have a low bone mass. Severity of
neurological impairment (mobility status), malnutrition (body
weight z-score, feeding difﬁculty, low triceps skinfold measure-
ment), use of AEDs and previous history of fracture are associated
with a low BMD in children with CP. Thus, similar factors are
associated with fracture risk and low BMD in children with CP.
Correlation between bone mineral density and fracture risk in
children with cerebral palsy
At least two prospective cohort studies have demonstrated an
association between BMD or BMC and fracture in healthy children.
The ﬁrst prospective study was a 2-year follow-up of 6213 children
initially aged 10 years.23 An inverse association was observed
between fracture risk and BMD, as well an 89% increased fracture
risk per standard deviation decrease in size-adjusted BMC. In
another prospective study of 183 children at 8 years of age, a lower
BMD of the spine and total body (but not hip) at age 8 predicted
a higher fracture risk for the upper limb at puberty.24 There are
a few cross-sectional studies that demonstrate the association
between BMD and fractures in children with CP. In a study of
lumbar spine BMD in 48 children with spastic quadriplegic CP,
a signiﬁcantly lower z-score of 2.81 was seen in children with
a history of previous fracture, compared with a z-score of 2.11 in
those without a history of fracture.20
The other two studies measured BMD of the distal femur. In
a study of 85 non-ambulatory children, mostly with CP, a correla-
tion was demonstrated between history of fracture and BMD of the
distal femur when this was combined with body mass index
(BMI).25 The fracture risk rate was 33% or more with a BMD of
0.38 g/cm2 or lower in the group with a BMI of less than 17 kg/m2,
and a BMD of 0.74 g/cm2 or lower in the group with a BMI of 17 kg/
m2 or greater in non-ambulatory children.
In another study of 619 children with moderate-to-severe CP
or muscular dystrophy, a strong correlation was found between
fracture history and BMD z-score for the distal femur.26 A total of
35e42% of those with a BMD z-score less than 5 had suffered
a fracture, compared with 13e15% of those with a BMD z-score
greater than e1. The risk ratio was 1.06e1.15, with a 6e15%
increased risk of fracture for each 1.0 unit decrease in BMD z-score.
Thus BMD, particularly the lateral distal femur z-score, is useful
as it shows a good correlation with fracture risk. Unlike the situa-
tion in the elderly population with osteoporosis, the use of fracture
risk reduction as the standard for success of an intervention may
not be feasible in children with CP. In an editorial overview of the
effects of pharmacological agents on bone in childhood, it was
estimated that a formidable cohort size of 3422 children with
severe disabilities would have to be recruited if one were using
fracture prevention as the standard for therapeutic success.27 Such
a large cohort size was calculated using a 5% annual fracture rate,
a 40% treatment efﬁcacy (similar to that of bisphosphonates in the
reduction of fragility fractures in post-menopausal women), a 20%
effect of control therapy and 20% attrition. As bone fragility is
a major contributory factor in fracture in children with CP, and low
BMD shares similar risk factors, it is logical to think that BMDmight
be used as a surrogate outcome parameter to evaluate and monitor
therapy for bone health or fracture reduction in children with CP.
Assessment of bone mineral density in children with cerebral
palsy
BMD may be measured by DXA or quantitative computed
tomography (QCT). DXA is currently the method of choice for thediagnosis andmonitoring of BMD over time as it has good precision
and low irradiation exposure. The typical scanning time for coop-
erative children is about 1 minute per scan for the lumbar spine or
distal femur and 5e7 minutes for a whole-body scan. A normative
database of BMD in children is available.
QCT involvesmore than 10 times the amount of irradiation that is
used inDXA.QCT is notwidelyavailable inhospitals andhas a limited
paediatric normative database of BMD in children. However, there
are a number of limitations to the use of DXA studies for BMD.
In a DXA scan, the areal BMD (g/cm2) is derived by dividing the
BMD (g) within a deﬁned anatomical region by the projected area
of bone (cm2). The measured areal BMD (a two-dimensional
measurement of the three-dimensional bone) is thus inﬂuenced
by body size. For example, a study found that 19% of participants
had a low spine BMD with a z-score less than 2.0 on DXA,
compared with only 6% of participants when volumetric BMD
measurement from QCT was used.28
A low BMD in a childmay reﬂect the smaller body size or a lower
bone density, and longitudinal changes in BMD can reﬂect changes
in bone density, bone size or both. Thus, the use of DXA BMD
requires adjustments for body size, pubertal status and skeletal
maturity. Such adjustment may be difﬁcult in children with CP as
they are known to have a large variation in age of attainting
puberty, with a high prevalence of both delayed and advanced
skeletal maturity. In children with moderate-to-severe CP, 10% had
a delayed and 7% had an advanced skeletal age (relative to chro-
nological age) of more than 2 years.29
The measurement of total-body BMD/BMC or total-body-less-
head (TBLH) BMD/BMC (to eliminate the inﬂuence of the skull on
the result of whole-body DXA) has been attempted to lessen arte-
facts related to bone size.30 Another approach is the use of bone
mineral apparent density, an estimated vertebral volumetric BMD
using paired posteroanterior and lateral scans to determine
whether a low bone mass is due to small bone size or low BMD.31
Thus, the inﬂuence of bone size on BMD in DXA may be mini-
mized by the use of TBLH BMD or bone mineral apparent density.
Total-body BMD and spinal BMD were found to be more accu-
rate and reproducible than total-hip BMD, particularly in younger
children.32 Spine and TBLH BMC and areal BMD, adjusted for
absolute height or height age, or compared with paediatric refer-
ence data that provide age-, gender- and height-speciﬁc z-scores,
was recommended for children by the International Society for
Clinical Densitometry.18
Proper positioning in DXA can be difﬁcult for children with CP.
Many children with quadriplegic CP have severe deformity or
multiple joint contractures, for example scoliosis, pelvic obliquity,
windswept deformity of the hips or ﬂexion contracture of the
knees. In a simulated altered body posture resulting from only knee
contracture in children, the mean errors could be up to 4e6% for
BMD measurement.33 Further interference from artefacts from
previous surgery, such as hip varus derotation osteotomy, abnor-
mally healed fractures or the presence of a metallic implant in the
hip or spine may make scanning of the lumbar spine and hips
difﬁcult, if not impossible, in children with CP. In one study of 119
children, 20% (24/119) of children had an orthopaedic implant that
made whole-body scanning unusable, and in 17% (20/119) of the
children the only scan that could be obtained was a distal lateral
femur scan.34
Lateral distal femur scanning has been developed speciﬁcally for
children with CP as it is the common site of fractures at least in
children with CP. Around 36e80% of fractures in children with CP
occur around the knee,3,8 and this is a more readily usable region in
CP. The scanning region in the distal femur includes three areas: the
metaphysis (mostly trabecular bone), the diaphysis (mostly cortical
bone) and the diaphyseal-metaphyseal junction (the transitional
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cortical bone). It compensates to a certain extent for the inability of
DXA to distinguish trabecular bone from cortical bone. In addition,
a normative reference of 256 healthy children aged 3e18 was pub-
lished in 2002 and later revised after the database of 821 healthy
children aged 5e18 was updated in 2009.35 BMD of the distal femur
(mean z-score 3.5) was much lower than that of the lumbar spine
(mean z-score2.0), and the correlation in BMD between these two
areas was poor in children with quadriplegic CP.9
Although not readily available, QCT can overcome some of the
limitations of DXA. DXA does not distinguish between cortical and
trabecular bone, which differ in their rate of bone turnover and
bone accrual pattern during growth. Trabecular bone in particular
is often more rapidly affected by disease or therapy, and a separate
analysis of trabecular bone BMD can be advantageous when
studying the response to therapeutic interventions.
Peripheral QCT (pQCT) can provide an independent assessment
of trabecular and cortical bone in the appendicular skeleton. The
trabecular site is evaluated at an ultradistal area at a relative or
ﬁxed location from the end of the growth plate, and the cortical site
is evaluated along the shaft of the length of tibia or forearm. BMC,
volumetric BMD and the areas of the trabecular and cortical
compartments can be calculated at both sites.
The effect of growth on bone size in prepubertal children is
obviated by the use of volumetric BMD in QCT. Besides BMD, bone
fragility in children is also inﬂuenced by bone size, bone geometry
and bone strength, which are areas in which DXA is deﬁcient. Bone
strength is better delineated by QCT as the technique is able to
estimated cortical width and the endosteal and periosteal circum-
ference of the bone. The polar strength strain index can be calcu-
lated by considering the geometric properties (bone cross-sectional
area, cortical thickness and cortical area) and material properties
(volumetric BMD and cortical BMC) of the bone.
ThepQCTholds all the advantagesofQCTbutwith less irradiation
and a shorter scanning time. In addition, normative data for the
youngpopulationhavebecomeavailable in recent years.36However,
a single-scan pQCT may reduce the reproducibility. In a study
examining pQCT data for the proximal tibia in 35 children with CP,
a large variability in bone morphology and trabecular bone density
values along the length of the metaphysis was demonstrated, indi-
cating the difﬁculty of obtaining reproducible pQCT measures from
a single scan in the appendicular skeleton of children.37
Prevention of bone fragility and fractures in children with
cerebral palsy
Obviously, prevention of bone fragility and fractures is the best
strategy in order to avoid pain and suffering, muscle wasting andTable 1
Risk factors for fracture or low bone mass and measures for their prevention and/or trea
Risk factors for fracture or low bone mass Preve
Non-ambulation or GMFSC level V2,4,9 Stand
Low-
Immobilization:
Previous fracture6,10
Hip spica cast after hip osteotomy10e12
Avoi
Stabl
Poor nutrition:
Poor feeding from oro-motor difﬁculty4,6,9
Weight-for-age z-score15,22
Low triceps skinfold measurement9
Mult
Early
Abnormal vitamin D metabolism:
Low vitamin D status5
Use of AEDs5,9,17,21
Ensu
Vitam
Use o
Vitam
AED ¼ antiepileptic drugs; GMFCS ¼ Gross Motor Functional Classiﬁcation System.disuse osteoporosis, increased disability, complications from frac-
tures and missed school time in children with CP. All known risk
factors should be minimized.
Physical activity and standing weight-bearing should be
encouraged. Any stiffness of the major joints and extended periods
of immobilization should be avoided. Stable internal ﬁxation of any
osteotomy, particularly of the hip, will minimize the postoperative
duration of cast immobilization. Lower limb joint deformities,
particularly foot and ankle deformities not amenable to bracing,
may make standing or physical activities painful and not well
tolerated. Orthopaedic operations to correct lower limb joint
deformities in order to provide plantigrade feet and straight knees
will allow standing weight-bearing and physical exercise in chil-
dren with severe CP.
It is clear that the absence of weight-bearing loading andmuscle
forces leads to bone fragility and fracture risk, so it is logical to
introduce standing weight-bearing and physical exercise for chil-
dren with CP to improve their bone health. After an 8-month
weight-bearing physical activity intervention in 18 children with
CP, an increase in BMC and volumetric BMD was observed in the
femoral neck and proximal femur in the intervention group
compared with control subjects.38
In a randomized clinical trial of 26 non-ambulatory children
with severe CP, the treatment group who underwent a 50% increase
in regular standing were compared over a 9-month period with
a group with no increase in standing. Therewas an improvement in
lumbar spine BMD of 6% but no change in BMD in the proximal
tibia, as estimated by QCT, in the treatment group. The authors
concluded that longer periods of standing for non-ambulatory
children with CP may reduce the risk of vertebral fractures but
are unlikely to reduce the risk of lower limb fractures.39
In a study of 31 children with CP of level IeIV GMFCS, low-
magnitude, high-frequency vibration (30 Hz, 0.3 gravity) for 10
minutes per day for 6 months resulted in a greater increase in
cortical bone area and moments of inertia during the vibration
period compared with the control standing period.40 Another study
of 20 children with CP treated by side-alternating whole-body
vibration for 9 minutes per school day did not detect a positive
treatment effect on bone, as assessed by areal BMD.41 A recent
systematic review and meta-analysis concluded a signiﬁcant but
small improvement in hip areal BMD in postmenopausal women
and in tibial and spine volumetric BMD in children/adolescents
treated with this technique.42 As a noninvasive and non-
pharmacological intervention, low-magnitude, high-frequency
vibration therapy warrants further investigation in children
with CP.
A multidisciplinary feeding team approach with participation of
a child neurologist, speech therapist, occupational therapist andtment
ntive or treatment measures
ing weight-bearing 38,39
magnitude, high-frequency vibration40,42
d immobilization
e internal ﬁxation for hip osteotomy to minimize hip spica casting
idisciplinary feeding team approach43
use of Ryles tube, surgical correction of gastro-esophageal reﬂux or gastrostomy
re adequate vitamin D intake
in D treatment for rickets or osteomalacia5
f AEDs with the lowest impact on bone metabolism44
in D and calcium supplementation in children receiving AEDs45
Table 2
Advantages and disadvantages of DUAL-energy X-ray absorptiometry (DXA) and quantitative computed tomography (QCT) in the monitoring of bone mineral density (BMD)
DXA QCT
BMD Areal Volumetric
Inﬂuence of growth effect on body size Yes; needs adjustment (total-body/total-body-less-head
BMD or bone mineral apparent density)
No
Bone geometry assessment No Yes (bone cross-sectional area, cortical
thickness and cortical area)
Independent assessment of
trabecular and cortical bone
No Yes
Availability Widely available Not widely available
Scanning time Fast Long (less in pQCT)
Irradiation exposure Low High (less in pQCT)
pQCT ¼ peripheral quantitative computed tomography.
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ment of feeding problems. A beneﬁcial outcome was demonstrated
from oro-motor training in a local study with short-term follow-
up.43 Video-ﬂuoroscopic studies of swallowing are helpful to
identify a need for Ryles tube feeding or surgical correction of
gastro-esophageal reﬂux or gastrostomy.
Adequate vitamin D and calcium intake should be assured. A
period of 10e15 minutes of exposure to the sun three times a week
provides most of the vitamin D needed. Another convenient source
of vitamin D is vitamin D-fortiﬁed milk and food.
The use of AEDs should beminimized and the AEDwith the least
impact on bone health should be used. Studies suggested a differ-
ential impact of AEDs on vitamin D metabolism and BMD.
Phenytoin, phenobarbital and primidone are most consistently
associated with a negative impact on bone; carbamazepine and
valproate may also result in bone abnormalities, but data are
mixed; and lamotrigine may have limited (if any) effect.44
Vitamin D and calcium supplementation should be considered
in children with CP who have an insufﬁcient dietary intake and are
on chronic AED therapy. A large but non-signiﬁcant increase in
lumbar spine BMD was observed after vitamin D supplementation
in 13 children with CP and epilepsy who were living in residential
care, compared with a decreased BMD in the seven children who
did not receive supplements.45
Determination of vitamin D status is desirable in children with
CP who sustain fractures. A study showed that all 20 institution-
alized children and young adults with quadriplegic CP and a history
of long-bone fractures had radiological and biochemical evidence
of rickets or osteomalacia, and vitamin D treatment resulted in
marked clinical improvement with no recurrence of fracture during
the treatment period.5
Growth hormone may also be deﬁcient in children with CP. A
recent large-scale study of 46 childrenwith CP aged between 3 and
11 years showed that 70% of these children lacked normal growth
hormone secretion.46 Bone growth is largely dependent on growth
hormone before puberty, and thus growth hormone deﬁciency can
have a large impact on bone growth and bone health. In
a randomized controlled trial of growth hormone therapy in 10
children with CP, the therapy group showed a statistically signiﬁ-
cant improvement in height-for-age z-scores and spinal BMD
z-scores compared with the control group.47
Treatment of bone fragility in children with cerebral palsy
With the increasing accessibility of DXA, the introduction of the
web-based Fracture Risk Assessment Tool to calculate the absolute
fracture risk, and the availability of effective drug treatment for
osteoporosis, signiﬁcant progress has been made in the prevention
of fragility fractures in the elderly. Bisphosphonates are often the
ﬁrst-line treatment to prevent fragility fractures in post-
menopausal women.The initial experience of bisphosphonates in CP is promising, but
the experience is limited to small series. Only one study has re-
ported the use of oral risedronate, while other studies focused on
the use of intravenous pamidronate. In a randomized placebo-
controlled study of six pairs of non-ambulatory children with CP,
intravenous pamidronate at 3-monthly intervals for 1 year
produced an increase of 89% in BMD in the metaphyseal region of
the distal femur, and an improvement in z-score from 4.0 to 1.8
over the 18-month study period.48
In a study of 18 children with quadriplegic CP with a prior
fracture treated by intravenous pamidronate, the gain in BMD of
the spine was 47%, and that of the lateral distal femur was 65.7%,
and these children did not sustain more fractures.49
Another study of nine children with spastic quadriplegic CP
demonstrated an average increase in spinal z-score from 4.0
to2.8, and in distal femur z-score from3.6 to2.7 after 1 year of
treatment. Although most but not all gains in BMD were lost over
the ﬁrst 2 years after treatment, no patient sustained another
fracture over an average 3-year follow up.50
Similarly, in another study, the mean increase in BMD was 1.9
for spinal z-score and 1.6 for femoral neck z-score in 23 non-
ambulatory children with CP.51 On the whole, there was an
increased BMD in children with CP, with a range of increase in
z-score of 1.2e1.9 for the spine,1.6 for the femoral neck, and 1.1e2.2
for the distal femur after 1 year of treatment with intravenous
pamidronate.48,50,51 In two of the above studies, the treated chil-
dren did not sustain a fracture during the follow-up period.49,50
In a study focusing on the incidence of fracture before and after
1 year of treatment with pamidronate for 25 children with quad-
riplegic CP level GMFCS IV or V, the fracture rate signiﬁcantly
decreased from 30.6% per year to 13.0% per year.52 In these studies,
no adverse effects of treatment were noted.Conclusion
Non-ambulatory children with CP have an increased risk of
fractures. The risk factors of fracture or low bone mass and
the corresponding preventive measures are summarised in
Table 1.4e6,9,10e12,15,17,21,22,38e40,42e45 Weight-bearing activities
cannot be overemphasized. Optimization of nutrition and intake of
calcium and vitamin D, together with physical activity, should be
enforced. Bisphosphonates should be considered in children with
CP and a history of fracture and low bone mass. Growth hormone
replacement is useful in children with growth hormone deﬁciency,
which is common in children with CP. In addition, low-magnitude,
high-frequency vibration warrants further investigation.
Currently, BMD (total-body or of the distal femur), BMI or body
weight z-score may be used to predict fracture risk. BMD may be
used as a surrogate outcome parameter to monitor bone health or
to test the efﬁcacy of fracture prevention or treatment in children
S.-T. Ho / Journal of Orthopaedics, Trauma and Rehabilitation 16 (2012) 45e5050with CP. The advantages and disadvantages of DXA and QCT in the
measurement of BMD are summarised in Table 2.
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